School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Canopy Growth Corp CGC

Healthcare · Drug Manufacturers - Specialty & Generic

$0.83last close 2026-10-09 · market cap $340.34M · delayed data

Trailing returns

1M-13.76%
3M-15.09%
6M-24.13%
1Y-49.88%
5Y-99.37%

Basis: Adjusted daily closes.

What it does

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.

Open CGC in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies